Literature DB >> 3830086

Predictive clinical factors of visible vessel in bleeding peptic ulcer.

F Fuster, J M Piqué, J Terés, J M Bordas, R M Perez, J Rodés.   

Abstract

The endoscopic finding of a visible vessel in the base of a bleeding gastrointestinal lesion is a well-known indicator of the possibility of recurrent hemorrhage. We carried out a multivariate analysis of 277 patients with gastrointestinal hemorrhage, but no chronic liver disease, of the clinical history and parameters in relation to hemorrhage, in order to select patients at risk for this endoscopic picture. A clinical history of associated disease, the absence of ulcerogenic drug intake, presentation of bleeding in the form of hematemesis and active hemorrhage on admission had predictive value for visible vessel, The incidence of visible vessel was significantly greater in anastomotic stoma ulcers than in gastric and duodenal sulcers. On the basis of the clinical parameters mentioned, patients with a high probability of having a bleeding lesion with a visible vessel can be selected for priority endoscopy.

Entities:  

Mesh:

Year:  1987        PMID: 3830086     DOI: 10.1055/s-2007-1018217

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


  3 in total

1.  Heat probe thermocoagulation and pure alcohol injection in massive peptic ulcer haemorrhage: a prospective, randomised controlled trial.

Authors:  H J Lin; F Y Lee; W M Kang; Y T Tsai; S D Lee; C H Lee
Journal:  Gut       Date:  1990-07       Impact factor: 23.059

2.  Reduction of surgery and mortality rate of bleeding peptic ulcer by endoscopic haemostasis with alcohol.

Authors:  O Pascu; A Draghici; I Acalovschi
Journal:  Surg Endosc       Date:  1988       Impact factor: 4.584

3.  Bleeding duodenal ulcer. A prospective evaluation of risk factors for rebleeding and death.

Authors:  F J Branicki; J Boey; P J Fok; C J Pritchett; S T Fan; E C Lai; F P Mok; W S Wong; S K Lam; W M Hui
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.